Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch

Viatris has received U.S. FDA approval for Gwyn Lo™, a new once-weekly, low-dose estrogen contraceptive patch. The product, approved for women with a BMI under 30 kg/m², is expected to be commercially available in the US later this year.

This Wire brief sits within Fusion42's coverage of Femtech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.